P3 Health Partners Inc. (NASDAQ:PIII) Short Interest Up 72.0% in January

P3 Health Partners Inc. (NASDAQ:PIII) was the target of a significant growth in short interest in January. As of January 30th, there was short interest totaling 27,237 shares, a growth of 72.0% from the January 15th total of 15,836 shares. Based on an average trading volume of 29,534 shares, the short-interest ratio is currently 0.9 days. Approximately 0.5% of the company’s stock are short sold. Approximately 0.5% of the company’s stock are short sold. Based on an average trading volume of 29,534 shares, the short-interest ratio is currently 0.9 days.

Wall Street Analyst Weigh In

A number of analysts have recently commented on PIII shares. Lake Street Capital dropped their price target on P3 Health Partners from $20.00 to $12.50 and set a “buy” rating on the stock in a research report on Monday, November 17th. BTIG Research reiterated a “neutral” rating on shares of P3 Health Partners in a research note on Friday, December 12th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of P3 Health Partners in a report on Thursday, January 22nd. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $12.50.

Institutional Inflows and Outflows

An institutional investor recently raised its position in P3 Health Partners stock. Trinity Financial Advisors LLC increased its position in P3 Health Partners Inc. (NASDAQ:PIII) by 4.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,678 shares of the company’s stock after acquiring an additional 1,178 shares during the quarter. Trinity Financial Advisors LLC owned about 0.37% of P3 Health Partners worth $239,000 at the end of the most recent quarter. 7.75% of the stock is owned by institutional investors and hedge funds.

P3 Health Partners Stock Up 6.5%

PIII stock traded up $0.13 during midday trading on Friday, hitting $2.14. The company’s stock had a trading volume of 10,100 shares, compared to its average volume of 119,569. The firm’s 50-day moving average is $3.25 and its 200-day moving average is $6.21. The company has a current ratio of 0.32, a quick ratio of 0.32 and a debt-to-equity ratio of 2.29. P3 Health Partners has a 12 month low of $1.52 and a 12 month high of $12.36. The company has a market cap of $15.43 million, a PE ratio of -0.05 and a beta of 0.89.

P3 Health Partners (NASDAQ:PIII) last posted its earnings results on Thursday, November 13th. The company reported ($9.67) earnings per share (EPS) for the quarter, missing the consensus estimate of ($8.70) by ($0.97). P3 Health Partners had a negative net margin of 9.07% and a negative return on equity of 302.33%. The company had revenue of $345.25 million for the quarter, compared to the consensus estimate of $346.64 million. On average, equities research analysts forecast that P3 Health Partners will post -0.67 earnings per share for the current fiscal year.

P3 Health Partners Company Profile

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.